- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Orum Therapeutics Inc (475830)
Track today's live Orum Therapeutics (475830) share price, performance and key data on this page with our current KOSDAQ:475830 stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Orum Therapeutics share price on the KOSDAQ exchange. Use the dropdown to switch exchange for the 475830 share price, head to our technical summary section, which provides analysis on Orum Therapeutics share price buy/sell indicators using real-time data (or discuss the Orum Therapeutics (475830) stock price today with other investors in the Orum Therapeutics KQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current KQ:475830 share price (ISIN: KR7475830006) to enhance your trading decisions with our free investment tools and resources.
What Is the Orum Therapeutics Inc Share Price Today?
The Orum Therapeutics share price today is 15,320.
What Is the Stock Symbol for Orum Therapeutics Inc
The stock symbol (or 'ticker') for Orum Therapeutics Inc is "475830."
What Stock Exchange Does Orum Therapeutics Inc Trade On?
Orum Therapeutics Inc is listed and trades on the KOSDAQ stock exchange.
Is Orum Therapeutics Inc a Good Stock to Buy?
Determining whether Orum Therapeutics (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current KQ:475830 share price (ISIN: KR7475830006) to enhance your trading decisions with our free investment tools and resources.
What Is the Orum Therapeutics Inc Share Price Today?
The Orum Therapeutics share price today is 15,320.
What Is the Stock Symbol for Orum Therapeutics Inc
The stock symbol (or 'ticker') for Orum Therapeutics Inc is "475830."
What Stock Exchange Does Orum Therapeutics Inc Trade On?
Orum Therapeutics Inc is listed and trades on the KOSDAQ stock exchange.
Is Orum Therapeutics Inc a Good Stock to Buy?
Determining whether Orum Therapeutics (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
KOSDAQ
Currency in KRW
15,320
-490(-3.10%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14,990
15,740
52 wk Range
14,990
146,600
Trading near 52-week Low
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14,99015,740
52 wk Range
14,990146,600
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
475830 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
Orum Therapeutics adds two directors to board- Investing.com
- Orum Therapeutics adds two directors to board
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Earnings
Latest Release
14/08/2026
EPS / Forecast
2,940.00 / --
Revenue / Forecast
24.11M / --
Compare 475830 to Peers and Sector
Metrics to compare | 475830 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship475830PeersSector | |
|---|---|---|---|---|
P/E Ratio | 18.0x | −11.6x | −0.3x | |
PEG Ratio | −0.06 | −0.11 | 0.00 | |
Price/Book | 1.8x | 2.8x | 2.6x | |
Price / LTM Sales | 8,217.7x | 13.6x | 2.8x | |
Upside (Analyst Target) | - | 51.4% | 66.6% | |
Fair Value Upside | Unlock | 16.5% | 9.1% | Unlock |
Orum Therapeutics, Inc., a biopharmaceutical company, engages in the research and development of pharmaceuticals for cancer and immune diseases in South Korea and the United States. The company develops ORM-6151, which is in Phase I clinical trial for the treatment of acute myeloid leukemia and myelodysplastic syndromes; ORM-1153, which is in pre-clinical trial for the treatment of acute myeloid leukemia and hematologic malignancies; and ORM-1023, which is in pre-clinical trial for the treatment of small cell lung cancer and neuroendocrine tumor. It is also involved in the development of multiple programs for the treatment of solid tumors and immunology and inflammation; and E3 Ligase-DAC adaptor, an adaptor linker platform that conjugates protein degraders to antibodies and enables E3 ligase-based DACs. The company was founded in 2016 and is headquartered in Daejeon, South Korea.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Orum Therapeutics (KOSDAQ: 475830) Share Price Today?
The Orum Therapeutics stock price today is 15,320 KRW.
What Stock Exchange Does Orum Therapeutics (475830) Trade On?
Orum Therapeutics is listed and trades on the KOSDAQ.
What Is the Ticker (Stock Symbol) for Orum Therapeutics?
The stock symbol (also called a 'ticker') for Orum Therapeutics is "475830."
What Is the Current Orum Therapeutics Market Capitalisation?
As of today, Orum Therapeutics (KOSDAQ: 475830) market cap is 333.25B KRW.
What Is Orum Therapeutics's (475830) Earnings Per Share (TTM)?
The Orum Therapeutics EPS is currently 869.79 (Trailing Twelve Months).
Is 475830 a Buy or Sell From a Technical Analyst Perspective?
Based on today's Orum Therapeutics moving averages and other technical indicators, the daily buy/sell signal for 475830 stock is Strong Sell.
How Many Times Has Orum Therapeutics Stock Split?
Orum Therapeutics has split 0 times. (See the 475830 stock split history page for full effective split date and price information.)
How Many Employees Does Orum Therapeutics Have?
Orum Therapeutics has 24 employees, based on their latest Companies House report.
What is the current trading status of Orum Therapeutics (KOSDAQ: 475830)?
As of 31/10/2026, Orum Therapeutics (475830) is trading at a share price of 15,320 KRW, with a previous close of 15,810 KRW. The stock has fluctuated within a day range of 14,990 KRW to 15,740 KRW, while its 52-week range spans from 14,990 KRW to 146,600 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.